V Schwoebel

1.2k total citations
54 papers, 773 citations indexed

About

V Schwoebel is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, V Schwoebel has authored 54 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 27 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in V Schwoebel's work include Tuberculosis Research and Epidemiology (32 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers) and Pneumonia and Respiratory Infections (9 papers). V Schwoebel is often cited by papers focused on Tuberculosis Research and Epidemiology (32 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers) and Pneumonia and Respiratory Infections (9 papers). V Schwoebel collaborates with scholars based in France, Switzerland and Niger. V Schwoebel's co-authors include Mario Raviǵlione, Arnaud Trébucq, Zellweger Jp, Giovanni Battista Migliori, Judith Watson, M. Forßbohm, Kobto G. Koura, Alberto Piubello, Armand Van Deun and C. Durand and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and AIDS.

In The Last Decade

V Schwoebel

52 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V Schwoebel France 15 610 493 213 48 47 54 773
Àngels Orcau Spain 18 700 1.1× 591 1.2× 316 1.5× 33 0.7× 55 1.2× 61 935
Tore W. Steen Norway 12 412 0.7× 385 0.8× 118 0.6× 22 0.5× 79 1.7× 37 607
Anne Wajja Uganda 15 276 0.5× 178 0.4× 174 0.8× 19 0.4× 28 0.6× 17 545
María Eugenia Jiménez-Corona Mexico 14 609 1.0× 541 1.1× 296 1.4× 10 0.2× 45 1.0× 38 846
Andrei Dadu Denmark 14 784 1.3× 472 1.0× 272 1.3× 22 0.5× 52 1.1× 37 937
Achara Chaovavanich Thailand 12 535 0.9× 379 0.8× 69 0.3× 15 0.3× 36 0.8× 21 703
Patricia García de Olalla Spain 18 514 0.8× 448 0.9× 214 1.0× 11 0.2× 49 1.0× 31 779
April C. Pettit United States 14 446 0.7× 357 0.7× 132 0.6× 9 0.2× 86 1.8× 60 608
Mirjam I. Bakker Netherlands 20 793 1.3× 512 1.0× 238 1.1× 12 0.3× 87 1.9× 41 983
Francine Matthys Belgium 12 405 0.7× 275 0.6× 107 0.5× 9 0.2× 59 1.3× 23 507

Countries citing papers authored by V Schwoebel

Since Specialization
Citations

This map shows the geographic impact of V Schwoebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V Schwoebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V Schwoebel more than expected).

Fields of papers citing papers by V Schwoebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V Schwoebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V Schwoebel. The network helps show where V Schwoebel may publish in the future.

Co-authorship network of co-authors of V Schwoebel

This figure shows the co-authorship network connecting the top 25 collaborators of V Schwoebel. A scholar is included among the top collaborators of V Schwoebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V Schwoebel. V Schwoebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaumont, A. R., C. Durand, Martine Ledrans, et al.. (2021). Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study. BMJ Open. 11(11). e053201–e053201. 8 indexed citations
2.
Souleymane, Mahamadou Bassirou, Alberto Piubello, Nimer Ortuño‐Gutiérrez, et al.. (2020). High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss. European Respiratory Journal. 57(1). 2002250–2002250. 12 indexed citations
3.
Chiang, Chen‐Yuan, Arnaud Trébucq, Alberto Piubello, et al.. (2020). The looming threat of bedaquiline resistance in tuberculosis. European Respiratory Journal. 55(6). 2000718–2000718. 6 indexed citations
4.
Schwoebel, V, Arnaud Trébucq, Zacharie Kashongwe, et al.. (2020). Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries. EClinicalMedicine. 20. 100268–100268. 25 indexed citations
5.
Trébucq, Arnaud, V Schwoebel, Zacharie Kashongwe, et al.. (2017). Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries. The International Journal of Tuberculosis and Lung Disease. 22(1). 17–25. 109 indexed citations
6.
Ngabonziza, Jean Claude Semuto, Awa Ba-Diallo, Elisa Tagliani, et al.. (2017). Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide. PLoS ONE. 12(10). e0187211–e0187211. 12 indexed citations
7.
Adjobimey, Mênonli, et al.. (2016). Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin. The International Journal of Tuberculosis and Lung Disease. 20(8). 1055–1059. 18 indexed citations
8.
Guinard, Anne, et al.. (2012). Collective outbreak of food poisoning due to Toxoplasma gondii associated with the consumption of lamb meat, Aveyron (France), November 2010.. 195–197. 1 indexed citations
9.
Rivière, Stéphanie, et al.. (2008). Predictors of symptoms of post-traumatic stress disorder after the AZF chemical factory explosion on 21 September 2001, in Toulouse, France. Journal of Epidemiology & Community Health. 62(5). 455–460. 14 indexed citations
10.
Verger, Pierre, et al.. (2006). French experiences with Health Impact Assessment of disasters. European Journal of Public Health. 17(1). 3–4. 3 indexed citations
11.
Lévy-Brühl, D, et al.. (2003). BCG et tests tuberculiniques : évolutions de la politique vaccinale française. Archives de Pédiatrie. 10(5). 482–486. 1 indexed citations
12.
Schwoebel, V, Maria Luisa Moro, Francis Drobniewski, et al.. (2000). Recomendaciones europeas en materia de vigilancia de resistencias a fármacos antituberculosos. Eurosurveillance. 5(10). 104–106. 1 indexed citations
13.
Antoine, D, V Schwoebel, J Veen, Mario Raviǵlione, & Hans L. Rieder. (1998). Surveillance de la tuberculose dans la Région Europe de l'OMS, 1995-1996. Eurosurveillance. 3(11). 103–107.
14.
Schwoebel, V, B Decludt, S Haeghebaert, et al.. (1998). Multidrug resistant tuberculosis in France 1992-4: two case-control studies. BMJ. 317(7159). 630–631. 21 indexed citations
15.
16.
Schwoebel, V, Marie-Christine Delmas, F F Hamers, J Alix, & Jean‐Baptiste Brunet. (1996). Epidemiology News. Clinical Microbiology and Infection. 1(4). 286–288. 4 indexed citations
17.
Triol, Isabelle, et al.. (1996). Factors associated with tuberculosis at AIDS diagnosis in France. AIDS. 10(2). 223–228. 5 indexed citations
18.
Schwoebel, V, et al.. (1995). Factors associated with extrapulmonary tuberculosis as an AIDS-defining disease in Europe. Tubercle and Lung Disease. 76(4). 281–285. 6 indexed citations
19.
Schwoebel, V, Bruno Hubert, & J Grosset. (1994). Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccination. Tubercle and Lung Disease. 75(1). 44–48. 10 indexed citations
20.
Larouzé, Bernard, et al.. (1988). Clinical presentation of louse-borne relapsing fever among Ethiopian refugees in northern Somalia. Annals of Tropical Medicine and Parasitology. 82(5). 499–502. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Àngels Orcau Breakdown of academic impact, for papers by Tore W. Steen Breakdown of academic impact, for papers by Anne Wajja Breakdown of academic impact, for papers by María Eugenia Jiménez-Corona Breakdown of academic impact, for papers by Andrei Dadu Breakdown of academic impact, for papers by Achara Chaovavanich Breakdown of academic impact, for papers by Patricia García de Olalla Breakdown of academic impact, for papers by April C. Pettit Breakdown of academic impact, for papers by Mirjam I. Bakker Breakdown of academic impact, for papers by Francine Matthys
Rankless by CCL
2026